TIM-3 Alzheimer’s therapy is emerging as a groundbreaking approach in the field of Alzheimer’s research, leveraging the immune system's checkpoint molecules to tackle one of the most challenging aspects of the disease: the accumulation of amyloid plaques.Recent studies indicate that by inhibiting the TIM-3 molecule, microglia—essential immune cells in the brain—can be freed to combat these harmful plaques, resulting in significant cognitive improvement in animal models.